MAPK1 and neoplasm: Thus, it was deduced that the upregulated ZNF300 induced by cisplatin might inhibit MAPK/ERK pathway to suppress the proliferation and differentiation of tumour cells to promote them to enter a relatively slower growth or even a quiescent or senescent state to avoid the cytotoxic effect of chemotherapeutic drugs.